A rapid urinary test for combining PSA and zinc to enhance prostate cancer diagnosis: results from a prospective study [0.03%]
一项结合PSA和锌的前列腺癌诊断快速尿检测试的前瞻性研究结果
Daniele Amparore,Sabrina De Cillis,Davide Zamengo et al.
Daniele Amparore et al.
Background: The need for simple, non-invasive biomarkers for prostate cancer (PCa) diagnosis is increasing. Urinary PSA (uPSA) and Zinc (uZinc) are emerging as potential PCa risk indicators. This study aimed to develop a ...
Infection risks and biopsy-associated complications in prostate cancer diagnosis: a review of recent literatures [0.03%]
前列腺癌诊断中的感染风险和活检相关并发症近期文献回顾
Pavlov Valentin Nikolaevich,Akinyemi Olalekan Samuel,Urmantsev Marat Fayazovich et al.
Pavlov Valentin Nikolaevich et al.
Background: Prostate cancer is the second most commonly diagnosed cancer worldwide. Prostate biopsy, essential for definitive diagnosis, has evolved significantly with new technologies and techniques. Transrectal ultrasou...
Evaluating PI-RADS lesions and clinically significant prostate cancer in Black and Asian men: a PREVENT randomized clinical trial secondary analysis [0.03%]
PI-RADS评分和临床显著性前列腺癌在黑人和亚洲男性中的评估：PREVENT随机临床试验的二次分析
Conor B Driscoll,Nicole Handa,Mitchell M Huang et al.
Conor B Driscoll et al.
Purpose: Non-White patients are poorly represented in prostate cancer trials. MRI PI-RADS scoring was developed in primarily White populations, but prostate cancer differs in non-White men. We aimed to explore differences...
Chasing the Culprit: targeting metastatic index lesions in oligometastatic hormone-sensitive prostate cancer [0.03%]
追根溯源：寡转移性激素敏感性前列腺癌患者中靶向转移病灶治疗
Salvatore Cozzi,Thomas Zilli
Salvatore Cozzi
Antonio Franco,Riccardo Lombardo,Cosimo De Nunzio
Antonio Franco
AI-aided diagnostic performance for prostate MRI: systematic review and meta-analysis [0.03%]
人工智能辅助诊断前列腺MRI的系统回顾和荟萃分析
Xin-Ru Xie,Ying Hou,Shuai Shan et al.
Xin-Ru Xie et al.
Background: AI is increasingly integrated within prostate cancer diagnosis pathway. Purpose: To provide estimates of diagnostic accurac...
The role of the human microbiome in prostate cancer: a systematic review from diagnosis to treatment [0.03%]
人体微生物组在前列腺癌诊疗中的作用：系统性综述研究
Alfredo Distante,Davide Garino,Clara Cerrato et al.
Alfredo Distante et al.
Background: Prostate cancer (PC) heterogeneity and treatment resistance remain major clinical challenges, with emerging evidence implicating the microbiome as a key modulator of disease pathogenesis. While microbial dysbi...
Publisher Correction: Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer [0.03%]
校正：在激素敏感性前列腺癌早期停用LHRH激动剂后，单独使用阿比特龙/泼尼松导致的睾酮抑制和恢复情况
Autumn Gagnon,Caiwei Zhong,Wanling Xie et al.
Autumn Gagnon et al.
Published Erratum
Prostate cancer and prostatic diseases. 2025 Nov 18. DOI:10.1038/s41391-025-01055-7 2025
Augmented Reality PSMA-3D guided robotic pelvic lymph node dissection (PLND) in prostate cancer patients [0.03%]
增强现实PSMA-3D引导的机器人前列腺癌患者盆腔淋巴结清扫术(PLND)
L Bianchi,A Mottaran,B Bortolani et al.
L Bianchi et al.
Background and objective: Intraoperative identification of suspicious lymph node metastases (LNM) detected at PSMA-PET is key to achieve optimal surgical outcomes of robot-assisted radical prostatectomy (RARP) with pelvic...